vs
GRID DYNAMICS HOLDINGS, INC.（GDYN）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
GRID DYNAMICS HOLDINGS, INC.的季度营收约是Vericel Corp的1.1倍（$104.1M vs $92.9M），Vericel Corp净利率更高（25.0% vs -1.4%，领先26.4%），Vericel Corp同比增速更快（23.3% vs 3.7%），过去两年Vericel Corp的营收复合增速更高（34.6% vs 12.0%）
Escape Dynamics Inc.是一家总部位于科罗拉多州的科技企业，活跃于2010年至2015年，核心业务方向是研发可单级入轨、依靠电磁驱动的可重复使用航天飞机，并推动该项目实现商业化落地。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
GDYN vs VCEL — 直观对比
营收规模更大
GDYN
是对方的1.1倍
$92.9M
营收增速更快
VCEL
高出19.6%
3.7%
净利率更高
VCEL
高出26.4%
-1.4%
两年增速更快
VCEL
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.1M | $92.9M |
| 净利润 | $-1.5M | $23.2M |
| 毛利率 | 34.8% | 78.7% |
| 营业利润率 | 61.7% | 24.1% |
| 净利率 | -1.4% | 25.0% |
| 营收同比 | 3.7% | 23.3% |
| 净利润同比 | -150.6% | 17.3% |
| 每股收益（稀释后） | $-0.02 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDYNVCEL
| Q1 26 | $104.1M | — | ||
| Q4 25 | $106.2M | $92.9M | ||
| Q3 25 | $104.2M | $67.5M | ||
| Q2 25 | $101.1M | $63.2M | ||
| Q1 25 | $100.4M | $52.6M | ||
| Q4 24 | $100.3M | $75.4M | ||
| Q3 24 | $87.4M | $57.9M | ||
| Q2 24 | $83.0M | $52.7M |
净利润GDYNVCEL
| Q1 26 | $-1.5M | — | ||
| Q4 25 | $306.0K | $23.2M | ||
| Q3 25 | $1.2M | $5.1M | ||
| Q2 25 | $5.3M | $-553.0K | ||
| Q1 25 | $2.9M | $-11.2M | ||
| Q4 24 | $4.5M | $19.8M | ||
| Q3 24 | $4.3M | $-901.0K | ||
| Q2 24 | $-817.0K | $-4.7M |
毛利率GDYNVCEL
| Q1 26 | 34.8% | — | ||
| Q4 25 | 34.0% | 78.7% | ||
| Q3 25 | 33.3% | 73.5% | ||
| Q2 25 | 34.1% | 73.7% | ||
| Q1 25 | 36.8% | 69.0% | ||
| Q4 24 | 36.9% | 77.6% | ||
| Q3 24 | 37.4% | 71.9% | ||
| Q2 24 | 35.6% | 69.5% |
营业利润率GDYNVCEL
| Q1 26 | 61.7% | — | ||
| Q4 25 | 0.5% | 24.1% | ||
| Q3 25 | -0.2% | 5.1% | ||
| Q2 25 | -0.1% | -3.2% | ||
| Q1 25 | -2.0% | -24.3% | ||
| Q4 24 | 1.3% | 24.5% | ||
| Q3 24 | 2.4% | -4.3% | ||
| Q2 24 | 0.0% | -11.5% |
净利率GDYNVCEL
| Q1 26 | -1.4% | — | ||
| Q4 25 | 0.3% | 25.0% | ||
| Q3 25 | 1.1% | 7.5% | ||
| Q2 25 | 5.2% | -0.9% | ||
| Q1 25 | 2.9% | -21.4% | ||
| Q4 24 | 4.5% | 26.3% | ||
| Q3 24 | 4.9% | -1.6% | ||
| Q2 24 | -1.0% | -8.9% |
每股收益（稀释后）GDYNVCEL
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.01 | $0.46 | ||
| Q3 25 | $0.01 | $0.10 | ||
| Q2 25 | $0.06 | $-0.01 | ||
| Q1 25 | $0.03 | $-0.23 | ||
| Q4 24 | $0.06 | $0.40 | ||
| Q3 24 | $0.05 | $-0.02 | ||
| Q2 24 | $-0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $327.5M | $137.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $530.1M | $354.6M |
| 总资产 | $605.0M | $488.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GDYNVCEL
| Q1 26 | $327.5M | — | ||
| Q4 25 | $342.1M | $137.5M | ||
| Q3 25 | $338.6M | $135.4M | ||
| Q2 25 | $336.8M | $116.9M | ||
| Q1 25 | $325.5M | $112.9M | ||
| Q4 24 | $334.7M | $116.2M | ||
| Q3 24 | $231.3M | $101.7M | ||
| Q2 24 | $256.0M | $102.5M |
股东权益GDYNVCEL
| Q1 26 | $530.1M | — | ||
| Q4 25 | $542.1M | $354.6M | ||
| Q3 25 | $537.7M | $321.9M | ||
| Q2 25 | $532.2M | $306.8M | ||
| Q1 25 | $517.4M | $295.5M | ||
| Q4 24 | $517.8M | $292.0M | ||
| Q3 24 | $400.2M | $257.5M | ||
| Q2 24 | $388.4M | $243.0M |
总资产GDYNVCEL
| Q1 26 | $605.0M | — | ||
| Q4 25 | $612.9M | $488.0M | ||
| Q3 25 | $613.2M | $453.3M | ||
| Q2 25 | $608.9M | $435.6M | ||
| Q1 25 | $590.9M | $424.6M | ||
| Q4 24 | $592.2M | $432.7M | ||
| Q3 24 | $477.3M | $390.4M | ||
| Q2 24 | $443.6M | $376.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $15.0M |
| 自由现金流经营现金流 - 资本支出 | — | $12.8M |
| 自由现金流率自由现金流/营收 | — | 13.8% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | — | $24.7M |
8季度趋势，按日历期对齐
经营现金流GDYNVCEL
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | $15.0M | ||
| Q3 25 | $7.0M | $22.1M | ||
| Q2 25 | $14.4M | $8.2M | ||
| Q1 25 | $9.4M | $6.6M | ||
| Q4 24 | $7.1M | $22.2M | ||
| Q3 24 | $9.2M | $10.2M | ||
| Q2 24 | $10.7M | $18.5M |
自由现金流GDYNVCEL
| Q1 26 | — | — | ||
| Q4 25 | $6.1M | $12.8M | ||
| Q3 25 | $2.9M | $19.5M | ||
| Q2 25 | $10.2M | $81.0K | ||
| Q1 25 | $6.0M | $-7.6M | ||
| Q4 24 | $4.4M | $8.5M | ||
| Q3 24 | $5.9M | $-9.2M | ||
| Q2 24 | $8.0M | $1.8M |
自由现金流率GDYNVCEL
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | 13.8% | ||
| Q3 25 | 2.8% | 28.8% | ||
| Q2 25 | 10.1% | 0.1% | ||
| Q1 25 | 6.0% | -14.5% | ||
| Q4 24 | 4.4% | 11.2% | ||
| Q3 24 | 6.8% | -15.9% | ||
| Q2 24 | 9.7% | 3.4% |
资本支出强度GDYNVCEL
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 2.4% | ||
| Q3 25 | 3.9% | 3.9% | ||
| Q2 25 | 4.1% | 12.9% | ||
| Q1 25 | 3.3% | 27.0% | ||
| Q4 24 | 2.6% | 18.3% | ||
| Q3 24 | 3.7% | 33.5% | ||
| Q2 24 | 3.2% | 31.8% |
现金转化率GDYNVCEL
| Q1 26 | — | — | ||
| Q4 25 | 32.34× | 0.65× | ||
| Q3 25 | 5.92× | 4.35× | ||
| Q2 25 | 2.73× | — | ||
| Q1 25 | 3.21× | — | ||
| Q4 24 | 1.56× | 1.12× | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDYN
暂无分部数据
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
